Percutaneous Vertebroplasty Vs. Sham for Osteoporotic Vertebral Compression Fractures Focusing on Pain and Economy.
Launched by SPINE CENTRE OF SOUTHERN DENMARK · Nov 20, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a procedure called percutaneous vertebroplasty (PVP) to see if it effectively reduces severe pain in people who have certain types of painful spinal fractures due to osteoporosis. The trial will compare the effects of PVP to a sham procedure, which means some participants will receive a fake treatment that doesn’t actually involve the PVP procedure. Researchers want to find out not only if PVP helps with pain relief but also how it affects patients’ quality of life and any related costs.
To participate in this trial, individuals must be 50 years or older and diagnosed with specific types of painful spinal compression fractures that can be seen on an MRI. Participants should have a significant level of back pain and must be able to understand Danish. Those with serious health issues or certain conditions that prevent them from safely undergoing the procedure will not be eligible. If chosen to participate, individuals can expect to be monitored for 12 weeks to assess how their pain and daily life improve after treatment. Overall, this trial aims to provide valuable information about the benefits and costs of treating osteoporotic spinal fractures.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 50+ and diagnosed with symptomatic osteoporotic spinal compression fractures between T6 and L5 (incl).
- • Focal tenderness on the level of the vertebral fracture.
- • Fractures verified with oedema of the relevant vertebra on the MRI STIR sequence
- • Osteoporotic Fractures type 1-4.
- • Fracture involves no more than 4 vertebral body levels.
- • PVP can be done in one session.
- • Back pain score measured on a Visual Analog Scale (VAS, 0 to 100) ≥ 60.
- • Able to understand and read Danish.
- • Written informed consent.
- • Relevant pain started ≤ 3 months prior to enrollment.
- Exclusion Criteria:
- • - Contra-indications for spine surgery.
- • Platelets \< 30 mia/l.
- • Osteoporotic Fractures type 5 and Pincer-type.
- • Complete collapse of the vertebral body precluding insertion of needle.
- • Presence of neurologic deficit.
- • Contraindications for MRI scanning.
- • Psychological or psychiatric disorder that is expected to interfere with compliance.
- • Active malignancy.
- • Mini Mental State Examination (MMSE) test score below 24.
- • History of chronic back pain requiring ongoing opiate use.
- • Systemic or local infection of the spine.
About Spine Centre Of Southern Denmark
The Spine Centre of Southern Denmark is a leading clinical research institution dedicated to advancing the understanding and treatment of spinal disorders. With a focus on innovative therapeutic approaches and evidence-based practices, the Centre conducts rigorous clinical trials aimed at improving patient outcomes and enhancing quality of life for individuals with spine-related conditions. Collaborating with a multidisciplinary team of healthcare professionals, researchers, and academic partners, the Spine Centre is committed to translating scientific findings into practical solutions that address the complexities of spinal health. Through its pioneering research initiatives, the Centre strives to be at the forefront of spinal care, contributing valuable insights to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Middelfart, Fyn, Denmark
Patients applied
Trial Officials
Mikkel Ø Andersen, MD
Principal Investigator
Sygehus Lillebælt
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported